Cite

HARVARD Citation

    Matsumoto, S. et al. (2017). Effect of treatment with 5‐lipoxygenase inhibitor VIA‐2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. Clinical cardiology. 40 (4), pp. 210-215. [Online]. 
  
Back to record